Astec LifeSciences profit and loss

Latest FY26

Revenue: ₹448cr+17.5% on FY25
EBITDA: −₹4.5cr−₹66.2 cr in FY25
Net profit: −₹80.9cr−₹135 cr in FY25
EPS: −₹37.79−₹68.71 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	439	448	381	458	628	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	4.8	5.1	5.6	5.6	13.1
	444	453	387	464	641
	286	270	249	319	461
	2.6	28.0	48.1	0.5	−59.6
	63.2	62.9	61.1	61.7	52.3
	29.9	34.5	36.7	25.2	20.7
	45.2	44.9	43.7	36.3	33.7
	94.9	91.3	89.5	83.1	98.4
	521	532	528	526	606
	−7.3	−4.5	−66.2	−5.9	76.3
	−52.5	−49.4	−110	−42.2	42.6
Profit
	−77.6	−78.9	−141	−61.7	34.9
	−2.1	−2.1	0.0	0.0	0.0
	−79.7	−81.0	−141	−61.7	34.9
	0.0	0.0	0.0	0.0	0.0
	−0.2	−0.2	−6.3	−14.9	9.3
	−0.2	−0.1	−6.3	−14.9	9.4
	−79.5	−80.9	−135	−46.9	25.6
	−79.5	−80.9	−135	−46.9	25.6
	0.6	0.5	0.2	−0.6	−0.2
	−79.0	−80.4	−135	−47.5	25.4
	−79.6	−80.9	−135	−46.9	25.6
	0.0	0.0	0.0	0.0	0.0
Per share
	−₹35.71	−₹37.79	−₹68.71	−₹23.93	₹13.04
	−₹35.71	−₹37.79	−₹68.71	−₹23.93	₹13.04
Other comprehensive income — detail
	0.6	0.5	0.2	—	—
	0.8	0.6	0.2	−0.8	−0.3
	0.2	0.2	0.1	—	—
	—	—	—	−0.2	−0.1
	—	—	—	−0.0	0.0
	—	—	−0.0	—	—
	−79.0	−80.5	−135	−47.5	25.3
	0.0	0.0	0.0	0.0	0.0
Per share — as-filed variants
	−₹35.71	−₹37.79	−₹68.71	−₹23.93	₹13.04
	−₹35.71	−₹37.79	−₹68.71	−₹23.93	₹13.04
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	151	150	84.4	139	227
	34.4%	33.4%	22.1%	30.3%	36.1%
Adjusted (ex-exceptional items) — derived
	−77.6	−78.9	−141	−61.7	34.9
	−2.1	−2.1	0.0	0.0	0.0
	−77.4	−78.8	−135	−46.9	25.6
	−₹34.77	−₹36.81	−₹68.71	−₹23.93	₹13.04

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTEC₹581.05

Astec LifeSciences Limited

· Chemicals

Annual Quarterly₹ CrorePeersPUNJABCHEM MOL IPL INSECTICID DHARMAJ BHARATRAS ADVANCE HERANBAMcap ₹1,295 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	628.2	458.2	381.3	448.1	438.9
Other Income	13.1	5.6	5.6	5.1	4.8
Total Income	641.2	463.8	386.9	453.2	443.7
Expenses
+ Cost of Materials Consumed	460.8	318.8	248.9	270.5	285.5
+ Changes in Inventories	-59.6	0.5	48.1	28.0	2.6
+ Employee Benefit Expense	52.3	61.7	61.1	62.9	63.2
+ Finance Costs	20.7	25.2	36.7	34.5	29.9
+ Depreciation & Amortisation	33.7	36.3	43.7	44.9	45.2
+ Other Expenses	98.4	83.1	89.5	91.3	94.9
Total Expenses	606.3	525.6	527.9	532.1	521.4
EBITDA	76.3	-5.9	-66.2	-4.5	-7.3
EBIT	42.6	-42.2	-109.9	-49.4	-52.5
Profit
PBT before Exceptional Items	34.9	-61.7	-141.0	-78.9	-77.6
+ Exceptional Items	0.0	0.0	0.0	-2.1	-2.1
Pretax Income	34.9	-61.7	-141.0	-81.0	-79.7
+ Current Tax	0.0	0.0	0.0	0.0	0.0
+ Deferred Tax	9.3	-14.9	-6.3	-0.2	-0.2
Tax Expense	9.4	-14.9	-6.3	-0.1	-0.2
Net Income	25.6	-46.9	-134.7	-80.9	-79.5
+ Net Income — Continuing Ops	25.6	-46.9	-134.7	-80.9	-79.5
+ Other Comprehensive Income	-0.2	-0.6	0.2	0.5	0.6
Total Comprehensive Income	25.4	-47.5	-134.5	-80.4	-79.0
Net Income to Common	25.6	-46.9	-134.8	-80.9	-79.6
Minority Interest	0.0	0.0	0.0	0.0	0.0
Per Share
Basic EPS	13.04	-23.93	-68.71	-37.79	-35.71
Diluted EPS	13.04	-23.93	-68.71	-37.79	-35.71
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.2	0.5	0.6
+ Items NOT to be Reclassified to P&L	-0.3	-0.8	0.2	0.6	0.8
+ Tax on Items NOT to be Reclassified	—	—	0.1	0.2	0.2
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	-0.2	—	—	—
+ Items to be Reclassified to P&L	0.0	-0.0	—	—	—
+ Tax on Items to be Reclassified	—	—	-0.0	—	—
Comprehensive Income — Owners of Parent	25.3	-47.5	-134.6	-80.5	-79.0
Comprehensive Income — Non-controlling Interests	0.0	0.0	0.0	0.0	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	13.04	-23.93	-68.71	-37.79	-35.71
Diluted EPS — Continuing Operations	13.04	-23.93	-68.71	-37.79	-35.71
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	226.9	138.9	84.4	149.7	150.8
Gross Margin %	36.12	30.32	22.13	33.41	34.36
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	34.9	-61.7	-141.0	-78.9	-77.6
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-2.1	-2.1
Net Income Adj (tax-effected)	25.6	-46.9	-134.7	-78.8	-77.4
EPS Adj	13.04	-23.93	-68.71	-36.81	-34.77
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	—	10.00	10.00
Filed Debt Equity	1.00	1.00	—	—	0.99
Filed Dscr	1.00	0.00	—	—	-1.11
Filed Iscr	4.00	1.00	—	—	-2.71
Paid Up Equity Capital	19.6	19.6	—	22.3	22.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.